Iradimed Corp

IRMD

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001325618

SEC filings (opens in a new tab)

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Iradimed Corp changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of IRMD: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	127	1	139	+13
Shares	6.72M	12.0K	6.82M	+117.8K (+1.8%)
Value	$295.4M	$529.2K	$299.8M	+$4.88M (+1.7%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Iradimed Corp at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IRMD in Q2 2024
Institution	Shares	Value	% of portfolio
Liontrust Investment Partners LLP	64,396	$2.83M	0.04%
Abn Amro Investment Solutions	30,370	$1.33M	0.02%
Janus Henderson Group PLC	26,905	$1.18M	0.00%
Kings Path Partners LLC	24,008	$1.05M	0.50%
Norges Bank	16,500	$725.0K	0.00%
Sequoia Financial Advisors, LLC	12,918	$567.6K	0.01%
UBS Asset Management Americas Inc	12,031	$528.6K	0.00%
Jane Street Group, LLC	11,025	$484.4K	0.00%
Marshall Wace, LLP	10,531	$462.7K	0.00%
Y-Intercept (Hong Kong) Ltd	9,535	$419.0K	0.02%
ExodusPoint Capital Management, LP	8,987	$395.0K	0.00%
AQR Capital Management LLC	8,436	$370.7K	0.00%
D. E. Shaw & Co., Inc.	8,202	$360.4K	0.00%
Invesco Ltd.	7,081	$311.1K	0.00%
Magnetar Financial LLC	6,466	$284.1K	0.01%
XTX Topco Ltd	6,036	$265.2K	0.02%
Tudor Investment Corp Et Al	5,049	$221.9K	0.00%
Aviva PLC	4,811	$211.4K	0.00%
Sherbrooke Park Advisers LLC	4,741	$208.3K	0.04%
Bailard, Inc.	4,600	$202.1K	0.01%
Corebridge Financial, Inc.	4,331	$190.3K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	3,254	$143.0K	0.00%
1620 Investment Advisors, Inc.	565	$24.8K	0.02%
Meeder Asset Management Inc	453	$19.9K	0.00%
nVerses Capital, LLC	400	$17.6K	0.01%
Cornerstone Planning Group LLC	15	$664	0.00%
Innealta Capital, LLC	12	$527	0.00%
GWM Advisors LLC	3	$132	0.00%
Parallel Advisors, LLC	3	$132	0.00%

Sold out (16)

Institutions that held Iradimed Corp at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of IRMD in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Hillsdale Investment Management Inc.	97,400	$4.28M
Roubaix Capital, LLC	50,307	$2.21M
Fiera Capital Corp	28,741	$1.26M
Allianz Asset Management GmbH	22,854	$1.01M
Polar Asset Management Partners Inc.	20,000	$879.8K
Mirae Asset Global Investments Co., Ltd.	11,208	$475.6K
Denali Advisors LLC	5,700	$250.7K
Calamos Advisors LLC	5,073	$223.2K
American International Group, Inc.	3,603	$158.5K
Globeflex Capital L P	2,034	$89.5K
Catalyst Funds Management Pty Ltd	800	$35.2K
Metropolitan Life Insurance Co	465	$20.5K
CIBC Private Wealth Group, LLC	24	$1.03K
Harbor Investment Advisory, LLC	14	$616
Signaturefd, LLC	1	$44
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	1	$43

Not filed for Q2 2024 yet (1)

Institutions that held Iradimed Corp at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRMD in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	12,031	$529.2K